SR One Investors

Corporate venture capital arm of GlaxoSmithKlineВідповідно до джерел: 2SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. We have a team of investment professionals, located in the US and One - … One is the corporate venture capital arm of GlaxoSmithKline. SR One invests in early to late-stage biotechnology and healthcare companies, focusing on the United States, particularly in San Diego, Cambridge, and Boston. Learn MoreSR One - Crunchbase
Invests into
Headquarters:
Boston, the United States, Cambridge, San Diego
Employee Number:
1-10
Number Of Exists:
53
Founded Date:
1985